Breast cancer

• Highlights
• Introduction
• Risk Factors
• Prevention and Lifestyle Fa...
• Symptoms
• Diagnosis
• Prognosis
• Treatment
• Surgery
• Radiation
• Medications
• Chemotherapy
• Hormone Therapy
• Resources
• References

• In September 2007, Evista (raloxifene) was approved for prevention of breast cancer in postmenopausal women with osteoporosis, and postmenopausal women at high risk for invasive breast cancer. Raloxifene and tamoxifen are the only two drugs approved for breast cancer prevention in high-risk women.
• In March 2007, lapatinib (Tykerb) was approved in combination with capecitabine (Xeloda) for treatment of advanced HER2-positive breast cancer.
• In November 2006, trastuzumab (Herceptin) was approved for treatment of early-stage HER2-positive breast cancer. Trastuzumab is also approved for advanced HER2-positive breast cancer.

• The American College of Physicians’ 2007 guidelines recommend that women with a low risk for breast cancer talk to their doctor before starting to have mammogram screening at age 40. - 0 Comments
  Read More ›

Menopause

• Highlights
• Introduction
• Complications
• Symptoms
• Lifestyle Changes
• Medications
• Resources
• References

• The herbal remedy black cohosh is no better than placebo for treating hot flashes and night sweats, according to a 2006 study in the Annals of Internal Medicine.
• Most complementary and alternative medicines are ineffective for relieving menopausal symptoms, according to a 2006 review in the Archives of Internal Medicine.

• Short-term use of HRT remains an option for recently menopausal women who have a low risk for stroke, according to a 2007 statement from the North American Menopause Society (NAMS). However, NAMS recommends that women who are at risk for heart disease or breast cancer should consider other approaches for managing hot flashes.
• For women who want to discontinue HRT, gradually tapering off the medication or stopping it abruptly appears to make little difference in the recurrence of symptoms, suggests a 2006 study. A gradual approach may delay the reappearance of symptoms, but does not prevent them from returning.

Uterine fibroids and hysterectomy

• Highlights
• Introduction
• Causes
• Symptoms
• Risk Factors
• Complications
• Diagnosis
• Lifestyle Changes
• Medications
• Surgery
• Other Procedures
• Hysterectomy
• Resources
• References

Urinary tract infection

• Highlights
• Introduction
• Causes
• Symptoms
• Risk Factors
• Complications
• Diagnosis
• Treatment
• Medications
• Other Treatments
• Resources
• References

• UTIs are the most expensive of all urologic diseases, accounting for about $3.5 billion a year in medical costs, including $96.4 million in prescriptions.
• Over 60% of women will experience a UTI at least once in their lifetime. At least a third of women experience a UTI by the time they are 24 years old.
• Only 20% of UTIs occur in men. - 0 Comments
  Read More ›

Infertility in women

• Highlights
• Introduction
• The Reproductive System
• Risk Factors
• Causes
• Diagnosis
• Treatment
• Lifestyle Changes
• Medications
• Assisted Reproductive Techn...
• Complications of Assisted R...
• Resources
• References

Cervical cancer

• Highlights
• Introduction
• Causes
• Risk Factors
• Prognosis
• Symptoms
• Prevention
• Diagnosis
• Treatment for Cervical Intr...
• Treatment for Cervical Canc...
• Treatment for Invasive Cerv...
• Resources
• References

Smoking

• Highlights
• Introduction
• Nicotine Addiction
• Health Risks
• Secondhand Smoke
• Smoking Bans
• Quitting Smoking
• Symptoms of Withdrawal
• Failure to Quit
• Lifestyle Changes
• Resources
• References

• Smoking may worsen knee osteoarthritis in men. A study published in the Annals of Rheumatic Disease found that male smokers have more pain and cartilage loss than men who do not smoke. Previous studies have not found such a link.
• Smoking greatly increases the risk of age-related macular degeneration. - 0 Comments
  Read More ›